DuPont de Nemours, Inc. Work in process increased by 5.9% to $232.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 57.1%, from $541.00M to $232.00M. Over 5 years (FY 2020 to FY 2025), Work in process shows a downward trend with a -13.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $528.00M | $446.00M | $475.00M | $526.00M | $519.00M | $522.00M | $542.00M | $518.00M | $502.00M | $487.00M | $490.00M | $504.00M | $536.00M | $407.00M | $541.00M | $546.00M | $428.00M | $219.00M | $232.00M |
| QoQ Change | — | -15.5% | +6.5% | +10.7% | -1.3% | +0.6% | +3.8% | -4.4% | -3.1% | -3.0% | +0.6% | +2.9% | +6.3% | -24.1% | +32.9% | +0.9% | -21.6% | -48.8% | +5.9% |
| YoY Change | — | — | — | — | -1.7% | +17.0% | +14.1% | -1.5% | -3.3% | -6.7% | -9.6% | -2.7% | +6.8% | -16.4% | +10.4% | +8.3% | -20.1% | -46.2% | -57.1% |
| % of Inventories | 18.6% | 21.4% | 21.2% | 22.3% | 22.0% | 22.4% | 22.2% | 22.1% | 22.0% | 22.7% | 22.5% | 23.3% | 24.0% | 36.0% | 24.1% | 23.8% | 23.3% | 18.7% | 19.2% |
| Share Change | — | +2.8pp | -0.2pp | +1.1pp | -0.3pp | +0.4pp | -0.2pp | -0.1pp | -0.1pp | +0.7pp | -0.2pp | +0.8pp | +0.7pp | +12.1pp | -11.9pp | -0.3pp | -0.5pp | -4.6pp | +0.5pp |